This study investigates GLP-1R-related conditions. It uses a special imaging technique called PET/CT to look at how certain diseases can be seen in the body.
The study evaluates how well the PET/CT scan works in finding and understanding these conditions. It checks the scan's ability to correctly identify and assess the disease.
- Who can participate: Adults aged 18 and older with suspected or known malignant tumors can participate. They must provide informed consent and have a scheduled Exendin 4 PET/CT scan.
- Study details: Participants will undergo a PET/CT scan to assess their condition. A placebo is not used in this study.